This workstream involves several projects on pharmacokinetic (PK) dosing evaluation of antimicrobials in special patient populations including adult critically ill patients, critically ill paediatric patients, hospitalised patients such as transplant recipients, and patients receiving outpatient antimicrobial therapy

Clinical dosing studies will be led by Workstream 1 Lead, Dr Suzanne Parker, and she will be responsible for collating Clinical dosing studies’ status, progress and milestone reports and ensuring they are escalated to the Operations Committee or Steering Committee for consideration and advice.

The objective of clinical dosing studies is to generate new knowledge that will inform robust dosing regimens that achieve therapeutic exposures that can then be tested clinically in the translation projects.

Workstream 1 projects are listed below:

Workstream 1: Clinical dosing studies
Project Lead 
PNEUDOS 
Critically ill patient sub-population PK study: Infection site PK and optimised dosing of meropenem, piperacillin, ceftriaxone and penicillin-G in mechanically ventilated patients with ventilator-associated or community-acquired pneumonia (The PNEUDOS Study).   
SMARRT 
Critically ill adult patient sub-population PK study: SMARRT Study: SaMpling Antibiotics in Renal Replacement Therapy (RRT).
Critically ill adult patient sub-population PK study: multi-centre study of patients receiving life-support
Antifungal PK 
Critically ill adult patient sub-population PK study: Multinational study of antifungal PK
Ventriculitis EVDs 
Critically ill adult patient sub-population PK study: Optimising antimicrobial dosing for ventriculitis associated with external ventricular drains
Critically ill adult patient sub-population PK study: Asia-Pacific regional capacity-building for optimisation of antimicrobial exposure for the treatment of sepsis
PIMS 
Critically ill paediatric patient PK study: Antimicrobial dosing in paediatrics
OPTIONS 
Critically ill paediatric patient PK study: Gentamicin dosing in neonates (OPTIONS) and Indigenous paediatric patients
APET PK 
Critically ill paediatric patient PK study: Dosing in extracorporeal treatments
PK transplant 
Hospital-based PK study: Antimicrobial dosing in transplant patients
PK prophylaxis  
Hospital-based PK study: Antimicrobial prophylaxis dosing in high-risk surgery
OPAT 
Community-based study: Optimised parenteral antimicrobial dosing in the community
PK complex infection
Community-based study: Antimicrobial PK in chronic complex infection 
Dr Danny Tsai, and Dr Andrew Burke 
PK in STIs 
Community-based study: Antimicrobial PK to optimise treatment and reduce antimicrobial resistance for sexually transmitted infections